Variant report
Variant | nsv980024 |
---|---|
Chromosome Location | chr3:146709143-146728833 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:27)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:27 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:146723668-146723949 | IMR90 | lung: | n/a | chr3:146723818-146723829 |
2 | CEBPB | chr3:146723680-146723890 | HepG2 | liver: | n/a | chr3:146723818-146723829 |
3 | CEBPB | chr3:146715450-146715793 | HepG2 | liver: | n/a | n/a |
4 | CTCF | chr3:146726178-146726268 | ProgFib | skin: | n/a | n/a |
5 | CTCF | chr3:146713299-146713335 | GM13977 | blood: | n/a | n/a |
6 | CTCF | chr3:146724986-146725012 | Medullo | brain: | n/a | n/a |
7 | CTCF | chr3:146718231-146718297 | GM13976 | blood: | n/a | n/a |
8 | FOXA1 | chr3:146726619-146726865 | T-47D | breast: | n/a | n/a |
9 | FOXA1 | chr3:146725521-146725759 | T-47D | breast: | n/a | n/a |
10 | FOXA1 | chr3:146725431-146725735 | T-47D | breast: | n/a | n/a |
11 | GATA3 | chr3:146709339-146710183 | SK-N-SH | brain: | n/a | chr3:146709708-146709729 |
12 | GATA3 | chr3:146725412-146725785 | T-47D | breast: | n/a | n/a |
13 | GATA3 | chr3:146709423-146710212 | SK-N-SH | brain: | n/a | chr3:146709708-146709729 |
14 | IRF1 | chr3:146728805-146728950 | K562 | blood: | n/a | n/a |
15 | JUN | chr3:146718153-146718379 | HepG2 | liver: | n/a | chr3:146718261-146718274 |
16 | JUND | chr3:146718160-146718415 | HepG2 | liver: | n/a | n/a |
17 | JUND | chr3:146725553-146725681 | HepG2 | liver: | n/a | n/a |
18 | MAFK | chr3:146715502-146715746 | HepG2 | liver: | n/a | n/a |
19 | MAFK | chr3:146718295-146718328 | HepG2 | liver: | n/a | n/a |
20 | MAFK | chr3:146719568-146719609 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | MXI1 | chr3:146710578-146710591 | GM12878 | blood: | n/a | n/a |
22 | MYC | chr3:146718007-146718024 | K562 | blood: | n/a | n/a |
23 | POLR2A | chr3:146716191-146716317 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr3:146709403-146709562 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | POLR2A | chr3:146708971-146709329 | H1-neurons | neurons: | n/a | n/a |
26 | POLR2A | chr3:146715941-146716071 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | TCF12 | chr3:146717840-146718420 | SK-N-SH | brain: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:146724156..146724656-chr7:158811116..158812074,2 | MCF-7 | breast: | |
2 | chr3:146715446..146717460-chr3:146722255..146724620,2 | K562 | blood: | |
3 | chr3:146714192..146714735-chr3:146728166..146728967,2 | MCF-7 | breast: | |
4 | chr3:146715446..146717460-chr3:146722255..146724620,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-505P | TF binding region |
ENSG00000207156 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540456101 | chr3:146715458-146715459 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs137894191 | chr3:146715460-146715461 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs532340815 | chr3:146715492-146715493 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs148100108 | chr3:146715654-146715655 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs200441751 | chr3:146715664-146715665 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs564405559 | chr3:146715666-146715667 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs568152245 | chr3:146715695-146715696 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs183620686 | chr3:146715736-146715737 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs549646676 | chr3:146715742-146715743 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs569204464 | chr3:146715764-146715765 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs149459418 | chr3:146715980-146715981 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs571108061 | chr3:146715995-146715996 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs539771039 | chr3:146715996-146715997 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs558521052 | chr3:146715997-146715998 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs575270534 | chr3:146715998-146715999 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs555529248 | chr3:146716010-146716011 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs544230852 | chr3:146716029-146716030 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs377364429 | chr3:146716203-146716204 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs560118985 | chr3:146716204-146716205 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs532436005 | chr3:146716218-146716219 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs545822982 | chr3:146716267-146716268 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs562807750 | chr3:146716277-146716278 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs546971083 | chr3:146716305-146716306 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs566784150 | chr3:146716306-146716307 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs370435736 | chr3:146717878-146717879 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs142850254 | chr3:146717885-146717886 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs552115380 | chr3:146717888-146717889 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs527266852 | chr3:146717916-146717917 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs75072043 | chr3:146717959-146717960 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs570440821 | chr3:146717963-146717964 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs563628928 | chr3:146718010-146718011 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs539550403 | chr3:146718086-146718087 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs369915937 | chr3:146718107-146718108 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs112720301 | chr3:146718112-146718113 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs375267507 | chr3:146718128-146718129 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs190184305 | chr3:146718155-146718156 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs139219241 | chr3:146718156-146718157 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs139671251 | chr3:146718170-146718171 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs149772776 | chr3:146718238-146718239 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs572320373 | chr3:146718266-146718267 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs181337155 | chr3:146718274-146718275 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs144826288 | chr3:146718296-146718297 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs578030202 | chr3:146718316-146718317 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs542884273 | chr3:146718334-146718335 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs543973010 | chr3:146718344-146718345 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs563779202 | chr3:146718349-146718350 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs545565537 | chr3:146718371-146718372 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs529459206 | chr3:146718420-146718421 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs2134275 | chr3:146725217-146725218 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs534276285 | chr3:146725266-146725267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Autism | 21956041 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:146725200-146726000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr3:146725200-146727800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr3:146725600-146727800 | Enhancers | NHDF-Ad | bronchial |
4 | chr3:146726000-146726400 | Enhancers | Gastric | stomach |
5 | chr3:146726000-146726800 | Enhancers | Pancreas | Pancrea |
6 | chr3:146726000-146727000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr3:146726000-146727200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
8 | chr3:146726000-146727400 | Enhancers | HSMM | muscle |
9 | chr3:146726000-146727600 | Enhancers | Osteobl | bone |
10 | chr3:146726200-146727200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr3:146726800-146727600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr3:146727200-146727400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
13 | chr3:146727200-146727600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr3:146727200-146727600 | Enhancers | Placenta Amnion | Placenta Amnion |
15 | chr3:146727800-146730400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |